Serum concentration of pregnancy-specificβ-1-glycoprotein (SP-1) in normal and pathologic pregnancies
✍ Scribed by G. Tatra; G. Breitenecker; W. Gruber
- Publisher
- Springer
- Year
- 1974
- Tongue
- English
- Weight
- 298 KB
- Volume
- 217
- Category
- Article
- ISSN
- 0003-9128
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Maternal serum pregnancy specific beta‐1 glycoprotein (SP‐1) levels in the second trimester may be predictive of Down syndrome (DS). An enzyme immunoassay was used to measure SP‐1 sera from 46 DS pregnancies and 117 normal control women matched for maternal age, gestational age, and len
Pregnancy-specific 01-glycoprotein (SP I) was assayed by particle counting immunoassay in serum from 46 healthy female blood donors, 33 patients with benign mastopathy and 84 patients with breast cancer before operation and during follow-up. Values > I pg/ 'To whom reprint requests should be address
Ectopic production of placental proteins by a variety of nontrophoblastic epithetial tumors is well recognized. Pregnancy-specific beta-1 glycoprotein (SP-I), a recently described placental protein, has been detected both in the serum and tumors of patients with breast carcinoma. To assess the sign
Pregnancy-specific P,-glycoprotein, SP,, was measured in serum by competitive double antibody radioimmunoassay. Very low levels of SP, or SP,like activity were found in only 2 out of 85 sera from patients with cancer of the digestive tract, breast cancer, melanoma, and sarcoma, in 2 out of 11 sera f